Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
+10.1%/yr
vs -6.9%/yr prior
5Y CAGR
+3.7%/yr
Recent acceleration
Acceleration
+17.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | 97.54% | +4.5% |
| 2024 | 93.37% | +27.4% |
| 2023 | 73.31% | +0.3% |
| 2022 | 73.08% | -1.6% |
| 2021 | 74.26% | -8.8% |
| 2020 | 81.40% | -10.1% |
| 2019 | 90.57% | -7.1% |
| 2018 | 97.48% | +1.3% |
| 2017 | 96.20% | +1.4% |
| 2016 | 94.89% | - |